Cognitive Disorders
GLP-1s tied to a ‘particularly noteworthy’ decrease in likelihood of a dementia diagnosis
Several glucagon-like peptide-1, or GLP-1, receptor agonists may be associated with reduced risk for a dementia diagnosis in older adults with diabetes, according to a recent study from Epic Research.
Lead exposure necessary to address ‘if we want to prevent chronic disease’
Low-level lead poisoning remains prevalent across the United States and globally, warranting screening and identification of those at highest risk, according to a recently published review.
Younger exposure to football linked to worse cognitive outcomes in later life
PHILADELPHIA — Among men who played American football, researchers found that exposure to the sport at a younger age was strongly associated with worse cognitive performance and resilience, particularly in those who lived to at least 60 years.
Risk for premature death, suicide significantly higher following psychiatric discharge
Individuals discharged from psychiatric inpatient care appeared vulnerable to premature death and suicidal behavior, according to a study published in JAMA Network Open.
Q&A: SAGE test catches cognitive impairment early in a ‘critical time’
A self-administered assessment tool was effective in identifying cognitive impairment vs. routine care in primary care settings, according to results recently published in Frontiers in Medicine.
FDA grants orphan drug designation to oral Huntington’s disease therapy
The FDA has granted orphan drug designation to an investigational oral therapeutic for the treatment of Huntington’s disease, according to the manufacturer.